Custom gene and antibody synthesis

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Genscript Inc. to purchase:

Qty 85 of Custom plasmid to antibody expression.
Qty 7 of Custom gene to antibody expression.
Shipping and Handling

Manufacturer to be Genscript Inc.
To be delivered in 30-45 days.

The statutory authority for this sole source requirement is 41 U.S.C. 1901(e)(2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-1923580) to Janna Weber at janna.weber@nih.gov by 5:00 pm eastern standard time August 22, 2018. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

.